PubMed

Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.

Moses R, Slobodniuk R, Boyages S, Colagiuri S, Kidson W, Carter J, Donnelly T, Moffitt P, Hopkins H.

Diabetes Care. 1999 Jan;22(1):119-24.PMID: 10333912 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.

Lund SS, Tarnow L, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag AA.

Eur J Endocrinol. 2008 Jan;158(1):35-46.PMID: 18166815 [PubMed - indexed for MEDLINE]Related articlesFree article

Repaglinide/troglitazone combination therapy: improved glycemic control in type 2 diabetes.

Raskin P, Jovanovic L, Berger S, Schwartz S, Woo V, Ratner R.

Diabetes Care. 2000 Jul;23(7):979-83.PMID: 10895850 [PubMed - indexed for MEDLINE]Related articlesFree article

The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.

Robinson AC, Burke J, Robinson S, Johnston DG, Elkeles RS.

Diabetes Care. 1998 May;21(5):701-5.PMID: 9589227 [PubMed - indexed for MEDLINE]Related articlesFree article

The efficacy of repaglinide monotherapy and in combination with metformin in Indonesian type 2 diabetes mellitus patients.

Soegondo S, Subekti I, Luthariana L.

Acta Med Indones. 2004 Jul-Sep;36(3):142-7.PMID: 15557683 [PubMed - indexed for MEDLINE]Related articles

Repaglinide versus glyburide: a one-year comparison trial.

Marbury T, Huang WC, Strange P, Lebovitz H.

Diabetes Res Clin Pract. 1999 Mar;43(3):155-66.PMID: 10369424 [PubMed - indexed for MEDLINE]Related articles

Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.

Chow CC, Tsang LW, Sorensen JP, Cockram CS.

Diabetes Care. 1995 Mar;18(3):307-14.PMID: 7555472 [PubMed - indexed for MEDLINE]Related articles

A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Dutch and German Repaglinide Study Group.

Wolffenbuttel BH, Landgraf R.

Diabetes Care. 1999 Mar;22(3):463-7.PMID: 10097930 [PubMed - indexed for MEDLINE]Related articlesFree article

Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.

Roberts VL, Stewart J, Issa M, Lake B, Melis R.

Clin Ther. 2005 Oct;27(10):1535-47.PMID: 16330290 [PubMed - indexed for MEDLINE]Related articles

Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study.

Dailey GE 3rd, Mohideen P, Fiedorek FT.

Clin Ther. 2002 Sep;24(9):1426-38.PMID: 12380634 [PubMed - indexed for MEDLINE]Related articles

Repaglinide in combination therapy with metformin in Type 2 diabetes.

Moses R.

Exp Clin Endocrinol Diabetes. 1999;107 Suppl 4:S136-9.PMID: 10522839 [PubMed - indexed for MEDLINE]Related articles

Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.

Horton ES, Clinkingbeard C, Gatlin M, Foley J, Mallows S, Shen S.

Diabetes Care. 2000 Nov;23(11):1660-5.PMID: 11092289 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

Fonseca V, Rosenstock J, Patwardhan R, Salzman A.

JAMA. 2000 Apr 5;283(13):1695-702. Erratum in: JAMA 2000 Sep 20;284(11):1384. PMID: 10755495 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study.

Lewin A, Lipetz R, Wu J, Schwartz S.

Clin Ther. 2007 May;29(5):844-55.PMID: 17697903 [PubMed - indexed for MEDLINE]Related articles

Repaglinide versus metformin in combination with bedtime NPH insulin in patients with type 2 diabetes established on insulin/metformin combination therapy.

Furlong NJ, Hulme SA, O'Brien SV, Hardy KJ.

Diabetes Care. 2002 Oct;25(10):1685-90.PMID: 12351462 [PubMed - indexed for MEDLINE]Related articlesFree article

Combination therapy for type 2 diabetes: repaglinide plus rosiglitazone.

Raskin P, McGill J, Saad MF, Cappleman JM, Kaye W, Khutoryansky N, Hale PM; Repaglinide/Rosiglitazone Study Group.

Diabet Med. 2004 Apr;21(4):329-35.PMID: 15049934 [PubMed - indexed for MEDLINE]Related articles

The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial.

Yale JF, Valiquett TR, Ghazzi MN, Owens-Grillo JK, Whitcomb RW, Foyt HL.

Ann Intern Med. 2001 May 1;134(9 Pt 1):737-45.PMID: 11329231 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus.

Abbasi F, Chu JW, McLaughlin T, Lamendola C, Leary ET, Reaven GM.

Metabolism. 2004 Feb;53(2):159-64.PMID: 14767866 [PubMed - indexed for MEDLINE]Related articles

One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes.

Hanefeld M, Brunetti P, Schernthaner GH, Matthews DR, Charbonnel BH; QUARTET Study Group.

Diabetes Care. 2004 Jan;27(1):141-7.PMID: 14693980 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study.

Madsbad S, Kilhovd B, Lager I, Mustajoki P, Dejgaard A; Scandinavian Repaglinide Group.

Diabet Med. 2001 May;18(5):395-401.PMID: 11472451 [PubMed - indexed for MEDLINE]Related articles